Milena Pavlovic, Lonneke Scheffer, Keshav Motwani, Chakravarthi Kanduri, Radmila Kompova, Nikolay Vazov, Knut Waagan, Fabian LM Bernal, Alexandre Almeida Costa, Brian Corrie, Rahmad Akbar, Ghadi S Al Hajj, Gabriel Balaban, Todd M Brusko, Maria Chernigovskaya, Scott Christley, Lindsay G Cowell, Robert Frank, Ivar Grytten, Sveinung Gundersen, Ingrid Hobæk Haff, Sepp Hochreiter, Eivind Hovig, Ping-Han Hsieh, Gunter Klambauer, Marieke L Kuijjer, Christin Lund-Andersen, Antonio Martini, Thomas Minotto, Johan Pensar, Knut Rand, Enrico Riccardi, Philippe A Robert, Artur Rocha, Andrei Slabodkin, Igor Snapkov, Ludvig M Sollid, Dmytro Titov, Cédric R Weber, Michael Widrich, Gur Yaari, Victor Greiff, and Geir Kjetil Sandve
Overview of immuneML.
Adaptive immune receptor repertoires (AIRR) are key targets for biomedical research as they record past and ongoing adaptive immune responses. The capacity of machine learning (ML) to identify complex discriminative sequence patterns renders it an ideal approach for AIRR-based diagnostic and therapeutic discovery. To date, widespread adoption of AIRR ML has been inhibited by a lack of reproducibility, transparency, and interoperability. immuneML addresses these concerns by implementing each step of the AIRR ML process in an extensible, open-source software ecosystem that is based on fully specified and shareable workflows. To facilitate widespread user adoption, immuneML is available as a command-line tool and through an intuitive Galaxy web interface, and extensive documentation of workflows is provided. We demonstrate the broad applicability of immuneML by (i) reproducing a large-scale study on immune state prediction, (ii) developing, integrating, and applying a novel method for antigen specificity prediction, and (iii) showcasing streamlined interpretability-focused benchmarking of AIRR ML.
bioRxiv, 2021-03-15.